RE:RE:RE:RE:RE:RE:When will get news on how may patients have been treated?Maybe you don’t, but other people care what I think.
I post because I’m still interested in the strategy behind this cancer indication, even if I question whether the CEO is up to the task. I was disappointed in the execution and performance. The oppportunity cost of this investment currently was just too great for me personally.